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Abstract
Motivation: Non-synonymous single nucleotide polymorphisms (nsSNPs) are single nucleotide
substitution occurring in the coding region of a gene and leads to a change in amino-acid sequence
of protein. The studies have shown these variations may be associated with disease. Thus, investigating
the effects of nsSNPs on protein function will give a greater insight on how nsSNPs can lead into disease.
Breast cancer is the most common cancer among women causing highest cancer death every year. BRCA1
and BRCA2 tumor suppressor genes are two main candidates of which, mutations in them can increase the
risk of developing breast cancer. For prediction and detection of the cancer one can use experimental or
computational methods, but the experimental method is very costly and time consuming in comparison with
the computational method. The computer and computational methods have been used for more than 30
years. Here we try to predict the clinical significance of BRCA1 and BRCA2 nsSNPs as well as the unknown
clinical significances. Nearly 500 BRCA1 and BRCA2 nsSNPs with known clinical significances retrieved
from NCBI database. Based on hydrophobicity or hydrophilicity and their role in proteins’ second structure,
they are divided into 6 groups, each assigned with scores. The data are prepared in the acceptable form
to the automated prediction mechanisms, Probabilistic Neural Network (PNN) and Deep Neural Network-
Stacked AutoEncoder (DNN).
Results: The preprocessed data is used for training and testing the PNN and DNN. With Jackknife cross
validation we show that the prediction accuracy achieved for BRCA1 and BRCA2 using PNN are 87.97%
and 82.17% respectively, while 95.41% and 92.80% accuracies achieved using DNN. The total required
processing time for the training and testing the PNN is 0.9 second and DNN requires about 7 hours
of training and it can predict instantly. both methods show great improvement in accuracy and speed
compared to previous attempts. The promising results imply that the intelligent methods are suitable and
applicable to such problems without human interference, with very high prediction speed.
Availability: XXXXX
Contact: bazargan@znu.ac.ir
Supplementary information: Supplementary data are available at Bioinformatics online.
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1 Introduction
Nowadays Artificial Intelligence (AI) plays an important role
in science (e.g. chemistry, physics, medicine and etc.). While
experimental methods are more reliable but they are also more
time consuming and expensive than computational methods.
Although computational methods may never get accurate
enough to replace experimental methods, but they can help
selecting and prioritizing to a small number of likely candidates
from pools of available data. One of the computational methods
used in medicine is Artificial Neural Networks (ANNs) which is
a computer program and inspired from animal’s nervous system.
ANNs consist of simple processing units, nodes (neurons), which
aggregates and processes according to its internal activation
function, then these units produce outputs. Every ANN consists
of layers including an input layer, some intermediate layers and
an output layer. The units (nodes) of each layer has connection
with the nodes of its next layer, although more complex patterns
of connections are possible. ANNs can be divided into two main
groups, supervised learning ANNs, and unsupervised learning
ANNs. Supervised learning ANNs need to be trained using
examples of the problem under investigation. In the training
process, the weights relating each connection between units
and parameters of the activation function in each unit of the
network are adjusted in a direction to reduce the output error.
By training an ANN with the training set, which is a set of
different, but related input patterns, The ANN can relate input
to output without using explicit algorithms for deciding the
appropriate output.
ANNs have been used in cancer detection and diagnosis for more
than 30 years (1,2,3) but as noted in a study, the fundamental
goals of cancer prediction and prognosis are different from the
goals of cancer detection/diagnosis. In cancer prediction one
tries to (i) predict cancer susceptibility, (ii) predict cancer
recurrence, (iii) predict cancer survivability. Prediction is more
useful than detection because in prediction one can get prepared
before the occurrence of cancer. Also in the study it has been
noted that almost all predictions use just four types of input
data (i) genomic data, (ii) proteomic data, (iii) clinical data,
(iv) combination of these data (4).
A non-synonymous SNP (nsSNP) is a single nucleotide
substitution occurring inside coding region of a gene, causing an
amino acid substitution in the corresponding protein product.
These changes can lead to a structural or functional change in
the protein product which may give a minor or major phenotypic
change or may absolutely have no effect. For example, a nsSNP
in the hemoglobin beta gene (substitution of glutamic acid by
Valine) is one cause for sickle cell anemia (7), also diabetes
has been correlated with a number of nsSNPs (6). A mutation
can affect protein folding and stability, protein function,
protein-protein interaction, protein expression and sub-cellular
localization (8) and they can be divided into two categories (i)
apparently random (Sporadic) mutations followed by somatic
selection (somatic mutations), (ii) pre-existing mutations in the
germline (germline mutations). Mutations can occur due to (i)
gain of function mutations that changes the normal gene into
an oncogen. (ii) Loss of function mutations that inactivates
tumor suppressor genes. (iii) drug resistance mutations that
overcomes the inhibitory effect of a drug on the targeted protein.
Nonsynonymous single nucleotide polymorphisms (nsSNPs) are
Fig. 1. The architecture of a typical PNN.
prevalent in genomes and are closely associated with inherited
diseases. To facilitate identifying disease-associated nsSNPs
from a large number of neutral nsSNPs, it is important to
develop computational tools to predict the nsSNP’s phenotypic
effect (disease-associated versus neutral).
Breast cancer is the most common cancer among women
causing highest cancer death every year(9,10,11). The major
susceptibility genes, BRCA1 and BRCA2, acting as a tumor
suppressor have been previously identified (12,13). Pathogenic
mutations in these genes increase the inherited predisposition
to breast cancer. Evidence are suggesting that genetic variants
may alter the breast cancer risk for those with BRCA1 or
BRCA2 mutations. There is a study reporting a relationship
between a woman BRCA2 SNPs profile and the age she develops
breast cancer (14). Another study on individuals carrying
inactivating germline mutations in BRCA1 shows that they have
an increased risk of developing cancer (5). So it’s essential to
identify those at risk. The risk estimates of developing breast
cancer in a woman who carries a BRCA1 or BRCA2 mutations
is from kindred with multiple cases of breast or ovarian cancer,
or both, range from 76 to 87% (4).
Variants with Unknown Clinical Significance (VUS) in BRCA1
or BRCA2 genes cause major problems because physicians do
not know whether the VUS is related to developing BC or
is neutral with respect to BC risk. Thus carriers of VUSs
cannot benefit from risk assessment, prevention and therapeutic
measures that are available to carriers of known significance
mutations. The recent increase in the available nsSNP data,
determining the clinical significance of VUS in BRCA1 and
BRCA2 has become an important clinical issue and doing it
automatically using the ANN is valuable. Here we use the
PNN, which is a supervised learning ANN and benefits from
speed and easy result interpretation. The network is trained
with nsSNP data of BRCA1 and BRCA2 to predict the clinical
significance of VUSs. We retrieve data from NCBI 1 with 449
nsSNP data of homo sapiens BRCA1 and 460 nsSNP data
of homo sapiens BRCA2 and then preprocess them. We train
PNN and use different methods of validation (e.g. jackknife and
cross-validation) and achieve different accuracies and use best
data model to train and test the DNN. We show that, given
enough data, both PNN and DNN can outperform other ANN
algorithms at accuracy and speed. Larger the training samples,
more will be the accuracy.
2 The Author 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
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Fig. 2. Deep Learning Structure used in this work.
2 Methods
2.1 Probbablistic neural network (PNN)
Strategies used to classify patterns in a way that they minimize
the expected risk are called "Bayes strategies". PNN introduced
by Specht is a result of the theory of statistical pattern
classification. In the fifties and sixties parametric methods
used to solve statistical pattern classification problems but
within last twenty years these methods are replaced by the
non-parametric approach (15). In the non-parametric method,
it is assumed that a functional form of probability densities
is unknown. Pattern classification procedures derived from
non-parametric estimates are convergent - when the length of
learning sequence increases - to Bayes’ rules. PNNs are applied
in many interesting fields and they implement non-parametric
estimations techniques in parallel fashion to benefit from fast
training and convergence to Bayes optimal decision surface (15).
The architecture of a typical PNN is as shown in fig.1.
The input layer without any computation distributes the input
neurons in the pattern layer. Neuron xij after receiving a
pattern x computes its output.
φij(x) =
1
(2pi)d/2σd
exp[− (x− xij)
T (x− xij)
2σ2
] (1)
where d denotes the dimension of the pattern vector x, σ is
the smoothing parameter and xij is the neuron vector and by
summarizing and averaging the output of all neurons belonging
to the same class, the summation layer neurons compute the
maximum likelihood of pattern x being classified into Ci.
Pi(x) =
1
(2pi)d/2σd
1
Ni
N∑
j=1
exp[− (x− xij)
T (x− xij)
2σ2
] (2)
Ni denotes the total number of sample in class Ci. The decision
layer unit will classify the pattern x in accordance with the
Bayes’ decision rule based on the output of all the summation
layer neurons if the a priori probabilities and losses associated
with making an incorrect decision for each class are the same
(15).
Cˆ(x) = arg max{pi(x)}; i = 1, 2, ...,m (3)
Where Cˆ(x) denotes the estimated class of the pattern x and m
is the total number of classes in the training samples.
2.2 Deep Neural Network-Stacked AutoEncoder
Todays modern technology influenced by many aspects of
machine-learning, from video content analysis to large scale
1 ncbi.nlm.nih.gov/snp
image processing(16), from self-driving car(17),to recommended
system(18). From the beginning the research intention of
pattern recognition was to replace human engineered features
by multilayer neural network, no suitable algorithm provided
for this goal since 1980s decade. The backpropagation used to
compute the gradient of an objective function by optimizing
weights(19).
Learning an undirected graphical model called a Gaussian
binary restricted Boltzmann machine (RBM) that has one
visible layer of linear variables with Gaussian noise and one
hidden layer. There is full connectivity between layers. The
connection weights (and biases) can be learned efficiently using
the contrastive divergence approximation to the log likelihood
gradient(20).
Auto-encoders are simple building-block for learning, each
of these blocks transform input data into outputs to create
more efficient form of data. One can build up most powerful
machine learning algorithm by combining these simple parts.
Auto-encoders were first introduced by Hinton for unsupervised
learning of back-propagation algorithm(21). After many years
auto-encoders take inner place in deep architectures, where
stacked auto-encoders combined with supervised top-layer.
These deep architectures show state-of-art results for many
challenging problems(23,24). The Encoder building block is
given in figure 2 Auto-encoders, mainly, are of two types; linear
auto-encoder and non-linear auto-encoder. Linear auto-encoder
is equivalent to Principle Component Analysis (PCA), also by
using nonlinear transfer function one can discover nonlinear
patterns of data. Boolean and Boltzmann learning machines
are famous non-linear models. De-noising auto-encoder is other
kind of auto-encoder that reconstructs corrupted patterns(24).
Auto-encoder can be defined by set of parameters (n, p, N, F,
G, A, B, X, Y, D) n and p are the positive integers, which
show the number of units for input/output and hidden layer.
N is the number of training samples and A is the class transfer
functions that relates G in hidden units to F in output layer. B is
the transfer functions that relates input units in set F to hidden
units. X ∈ R1 is an input vector for auto-encoder; auto-encoder
converts the vector X into another similar vector as follows:
z = h(wx+ b) (4)
h is the transfer function for each layer of auto-encoder, w is a
weight matrix and b is a bias vector, the decoder reverses this
process and converts back the z to x vector(25). Y is the target
vector. D measures the similarity over input layer units.
If we define A1 as a subset of A and B1 as a subset of B then
for any input we would like to find the parameters to transform
the input units in A1 to output units in B1 in which we want
to minimize the solution for:
minE(A1, B1) =min(A1, B1)
N∑
i=1
E(A1, B1) =
N∑
i=1
D(fA1,B1 (xtarget), ytarget)
(5)
Where fAB is the function that related A to B, D is similarity
measure and N is the number of training data (5).
We can add regularization to the cost function(equation1) and
create sparsity for auto-encoder. To compute cost functions for
encoder, usually L2 and sparsity regularization terms combine
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with mean square error term.
The hidden layers in auto-encoders are of two types named as
compressed and sparse. In compressed type, number of units
in hidden layer is less than input layer, so network tries to
combine features and reproduce new compressed features. But
in sparse auto-encoder, features are expanded (26). The network
structure which is used in this study is given in figure 2. Here we
defined simple stacked auto encoder as deep network to analyze
our dataset. We used three simple auto-encoders with hidden
node of size 300 in each one, these layers combined with one
softmax layer to create deep structure.
2.3 Data
Here, we used ncbi.nlm.gov/snp among all the nsSNP databases
because it is complete and also details are provided with each
data. for now, we only used nsSNPs and didn’t include indel
variations. We used our program to pre-process data which
translates DNA code to protein code (transcript ID for BRCA1:
NM 007294, transcript ID for BRCA2: NM 000059.3). The final
step was to make a good coding scheme for amino-acids (AAs)
so that PNN can achieve high accuracy at predicting the clinical
significance. We used hydropathy and propensity indices for
scoring AAs and divided them into 6 categories based on if an
AA is hydrophobic or hydrophilic and if it favors alpha-helices
or turns or beta sheets in its 2nd structure.
2.3.1 BRCA1
We retrieved 5591 data from the database and used our program
to apply variants, after applying nsSNP data our program
showed 1871 of them are the exonic variants of which 449 were
variants with known clinical significance. So we used these 449
data to train and test the PNN and DNN. We tried out 5
different methods to prepare our data and each time improved
it. Five different types of prepration used for data are as below:
1 - After application of SNPs, DNA sequences are converted to
number string using this scheme : a = 1 , c = 2 , g = 3 , d = 4.
2 - DNA sequences are converted to number string using this
scheme : All nodes are zero except for the node which is different
from main sequence node.
3 - DNA sequences are translated to AA sequences according to
their transcription ID and then AA sequences are converted to
number strings according to the scheme used to classify AAs.
4 - AA sequences are converted to number strings where all
digits are zero except changed ones.
5 - This model is the most important because it gave promising
results of accuracy and speed due to its short length and amount
of data fitted into its nodes. In this model we used just 3 nodes
to represent every SNP, first node dedicated to the location of
AA substitution caused by SNP while second and third nodes
are for old AA and new AA. Every data in this model contains
5 different information involving, AA substitution location ,
old and new AA’s hydrophilicity or hydrophobicity and their
favorite structure.
2.3.2 BRCA2
The same procedure was applied to BRCA2 data. As a raw data,
we had 7227 BRCA2 nsSNP, then after processing them with
our program we had 2972 coding nsSNP data. The program
showed that 460 of them are variant with known clinical
significance.
3 Results
Training and testing with 5th dataset resulted in the highest
accuracy that we could get out of PNN and DNN. The reason
why this dataset is the most suitable one is simple. Because it
has the shortest possible length for representing AA substitution
and provides enough information for AI so that it can classify
AA substitutions with sufficient accuracy.
Table 2 shows PNN accuracy at predicting AA substitution and
table 3 shows same results obtained using DNN.
Table 1. Accuracies achived training PNN
using different datasets
dataset number∗ BRCA1(%) BRCA2(%)
1 48.2 40.4
2 50.4 45.7
3 55.6 48.8
4 58.7 53.2
*prediction accuracies using 5th dataset
shows significant increase in accuracies
which are given at table 2 and table 3.
Table 2. PNN accuracy at predicting BRCA1 and
BRCA2 SNP’s clinical significance
Validation method BRCA1(%) BRCA2(%)
5-fold cross validation 78.40 79.13
10-fold cross validation 80.40 80.00
20-fold cross validation 85.45 80.22
Jackknife 87.97 82.17
Table 3. DNN accuracy at predicting BRCA1 and
BRCA2 SNP’s clinical significance
Validation method BRCA1(%) BRCA2(%)
5-fold cross validation 86.74 79.95
10-fold cross validation 92.04 81.14
20-fold cross validation 93.30 82.86
Jackknife 95.41 92.80
Table 4. PNN and Deeplearning evalution
benchmarks for BRCA1
Benchmark PNN DNN
Accuracy 87.97% 95.41%
Sensitivity 93.96% 79.73%
Specificity 62.35% 93.87%
F1-score 0.9268 0.8059
MCC 0.5914 0.7454
MCC : Matthews correlation coefficient
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Table 5. PNN and Deeplearning evalution
benchmarks for BRCA2
Benchmark PNN DNN
Accuracy 82.17% 92.80%
Sensitivity 87.72% 64.01%
Specificity 50.72% 90.12%
F1-score 0.8932 0.6723
MCC 0.3570 0.5807
4 Discussion
In this article, we have shown that choosing the right data (right
tool for the right job) will change the results. As shown in the
table 1 when we had chosen DNA sequence instead of protein
sequence our result would not be more than 50.4% and 45.7%
for BRCA1 and BRCA2 respectively.
As reported in (27) several studies have considered how
benign and pathogenic nsSNPs may be distinguished using only
sequence and structural aspects of the proteins in which they
occur, e.g. Wang and Moult in (28) used protein hydrophobic
core disruption to determine the proteins structural stability
indirectly. Here we have used hydrophobicity and hydrophilicity
alongside favorite second structure of the previous AA and new
AA to score the AAs substitution. Our results suggest that
this information will lead to the increase of the accuracy of
prediction making machine-learning methods a useful tool for
SNP prediction problems in a way that our method can be
practical to real-world applications. A clear limitation of our
study was the inability to use indel SNPs due to assumptions
made in the definition of the model.
Prediction accuracy difference for BRCA1 and BRCA2 is
because BRCA1 AA sequence length is 1863 AA while BRCA2
AA sequence consists of 3418 AAs. Since we have almost
the same number of AA substitution with known clinical
significance for both BRCA1 and BRCA2 , fraction of our
knowledge which we use to train AI for BRCA1 is almost twice
the knowledge that we have about BRCA2.
In order to evaluate the behavior of NNs, we have used five
well-known measures: accuracy, sensitivity, specificity, F1-score,
Mathews Correlation Coefficient (MCC). In general, sensitivity
indicates how well the NN can predict the actual positive (e.g.
a pathogenic sample as a pathogenic sample) and specificity
indicates how well the NN can identify the actual negative
(e.g. a benign sample as a benign sample). The F1-score is
the harmonic average of the precision and sensitivity. Best F1-
score is 1 while the worst F1-score is 0. MCC is a measure
to indicate the quality of learning where value of +1 shows
perfect prediction and value of 0 shows prediction quality no
better than r+1andom prediction and -1 shows a prediction in
total disagreement between prediction and observation. Values
of each measure for each gene and NN used are shown in tables
4 and 5.
As the result, it is shown that DNN can predict AA
substitutions with more accuracy due to its modern structure
and its efficiency.
According to (4) the lack of attention to the data validation
is one of the major problems in this field. As reported in the
article, 5-fold or 10-fold cross validation is sufficient for most
learning algorithms to be validated, however, we used a more
aggressive method to validate the learning quality of the NNs
which is jackknife cross-validation method in this process we
have used all but one sample iteratively to train the NNs.
Also, a common problem in this field is the imbalance problem,
in which the data set is dominated by a major class, so the
predictions have a bias toward that class. To check if our method
is affected by this problem or not, we performed the learning
and testing procedure using the same number of samples from
each class. The obtained result showed a minor (2-5%) change
in the accuracy of the final result that reported in the table 3.
In addition to the supervised learning algorithms reported
here, we have also use Self-Organizing Maps (SOM) to check
whether these algorithms can or can’t distinguish between
different classes. Resulted Maps suggested the inability of these
algorithms in the classification of nsSNPs.
5 Conclusion
In this article, we have used PNN and DNN to predict
the clinical significance of nsSNPs with unknown clinical
significance. Our data were obtained from NCBI database and
then we have used DNA sequence and Protein sequence and
2nd structural information to prepare our training and testing
data set. Among different datasets, protein dataset with a novel
model of showing nsSNP position and substitution showed best
results, then we used n-fold cross validations to validate our
results. Also, F1-score and MCC scores are reported to show
the quality of learning and prediction of NNs used.
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